Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Journal of Neuroinflammation
|
May 6, 2016
Differential expression of P2X7 receptor and IL-1β in nociceptive and neuropathic pain
Benjamin Luchting, Jens Heyn, Tobias Woehrle, et al.
Journal of Clinical Medicine
|
March 17, 2025
Natriuretic Peptides as a Predictor for Delirium After Cardiac Surgery: A Prospective Observational Study
Cyril Huisinga, Eric Struck, Lorenz Mihatsch, et al.
European Journal of Medical Research
|
December 17, 2008
Diagnosis and pre-operative management of multiple injured patients with explorative laparotomy because of blunt abdominal trauma
Jens Heyn, R Ladurner, A Ozimek, et al.
European Journal of Medical Research
|
May 28, 2008
Recurrent ischemic colitis in a patient with leiden factor V mutation and systemic lupus erythematous with antiphospholipid syndrome
Jens Heyn, S Buhmann, R Ladurner, et al.
Journal of Cardiothoracic Surgery
|
September 5, 2012
Daptomycin as supportive treatment option in patients developing mediastinitis after open cardiac surgery
Florian Weis, Jens Heyn, Christian L Hinske, et al.
Biochemical and Biophysical Research Communications
|
August 12, 2014
MicroRNA-665 is involved in the regulation of the expression of the cardioprotective cannabinoid receptor CB2 in patients with severe heart failure
Patrick Möhnle, Stefanie Veronika Schütz, Marc Schmidt, et al.
Retina (Philadelphia, Pa.)
|
September 17, 2024
EFFICACY AND SAFETY OF THE PROPOSED BIOSIMILAR AFLIBERCEPT, SDZ-AFL, IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: 52-Week Results From the Phase 3 Mylight Study
Arnaldo F Bordon, Peter K Kaiser, Armin Wolf, et al.
Retina (Philadelphia, Pa.)
|
March 31, 2026
Efficacy and Safety of the Proposed Biosimilar Aflibercept, SDZ-AFL, in Patients With Neovascular Age-Related Macular Degeneration: 52-Week Results From the Phase 3 Mylight Study: Erratum
Arnaldo F Bordon, Peter K Kaiser, Armin Wolf, et al.
Transfusion
|
July 10, 2025
Healthy volunteer stem cell donors followed up 10 years after stimulation with biosimilar filgrastim
Jens Heyn, Susanne Bräuninger, Petra Becker, et al.
Current Medical Research and Opinion
|
April 8, 2022
A review of the totality of evidence supporting the development and approval of a pegfilgrastim biosimilar (LA-EP2006)
Sanjiv S Agarwala, Ulrich Nagl, Xinghua Guo, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Journal of Neuroinflammation
|
May 6, 2016
Differential expression of P2X7 receptor and IL-1β in nociceptive and neuropathic pain
Benjamin Luchting, Jens Heyn, Tobias Woehrle, et al.
Journal of Clinical Medicine
|
March 17, 2025
Natriuretic Peptides as a Predictor for Delirium After Cardiac Surgery: A Prospective Observational Study
Cyril Huisinga, Eric Struck, Lorenz Mihatsch, et al.
European Journal of Medical Research
|
December 17, 2008
Diagnosis and pre-operative management of multiple injured patients with explorative laparotomy because of blunt abdominal trauma
Jens Heyn, R Ladurner, A Ozimek, et al.
European Journal of Medical Research
|
May 28, 2008
Recurrent ischemic colitis in a patient with leiden factor V mutation and systemic lupus erythematous with antiphospholipid syndrome
Jens Heyn, S Buhmann, R Ladurner, et al.
Journal of Cardiothoracic Surgery
|
September 5, 2012
Daptomycin as supportive treatment option in patients developing mediastinitis after open cardiac surgery
Florian Weis, Jens Heyn, Christian L Hinske, et al.
Biochemical and Biophysical Research Communications
|
August 12, 2014
MicroRNA-665 is involved in the regulation of the expression of the cardioprotective cannabinoid receptor CB2 in patients with severe heart failure
Patrick Möhnle, Stefanie Veronika Schütz, Marc Schmidt, et al.
Retina (Philadelphia, Pa.)
|
September 17, 2024
EFFICACY AND SAFETY OF THE PROPOSED BIOSIMILAR AFLIBERCEPT, SDZ-AFL, IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: 52-Week Results From the Phase 3 Mylight Study
Arnaldo F Bordon, Peter K Kaiser, Armin Wolf, et al.
Retina (Philadelphia, Pa.)
|
March 31, 2026
Efficacy and Safety of the Proposed Biosimilar Aflibercept, SDZ-AFL, in Patients With Neovascular Age-Related Macular Degeneration: 52-Week Results From the Phase 3 Mylight Study: Erratum
Arnaldo F Bordon, Peter K Kaiser, Armin Wolf, et al.
Transfusion
|
July 10, 2025
Healthy volunteer stem cell donors followed up 10 years after stimulation with biosimilar filgrastim
Jens Heyn, Susanne Bräuninger, Petra Becker, et al.
Current Medical Research and Opinion
|
April 8, 2022
A review of the totality of evidence supporting the development and approval of a pegfilgrastim biosimilar (LA-EP2006)
Sanjiv S Agarwala, Ulrich Nagl, Xinghua Guo, et al.
Page
of 6